STOCK TITAN

Orchestra BioMed: Perceptive reports 8.15% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) is the subject of an amended ownership report by Perceptive Advisors LLC, its managing member Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. They report the same shared beneficial ownership position of 6,537,606 shares, or 8.15%, with shared voting and dispositive power.

The Master Fund directly holds 5,037,606 common shares and pre-funded warrants exercisable for 1,500,000 shares at $0.0001 per share. A 9.99% beneficial-ownership limitation applies to exercise; the report says it permits exercise of all the warrants. The reported ownership percentage is based on 78,704,957 shares outstanding as of November 9, 2026, and assumes exercise of the warrants.

Shared beneficial ownership 6,537,606 shares Reported by Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd.
Ownership percentage 8.15% Based on 78,704,957 shares outstanding as of November 9, 2026, and assumes exercise of the pre-funded warrants.
Common shares held directly 5,037,606 shares Held directly by Perceptive Life Sciences Master Fund, Ltd.
Pre-funded warrants 1,500,000 shares Warrants held directly by Perceptive Life Sciences Master Fund, Ltd.; immediately exercisable subject to the beneficial-ownership limitation.
Warrant exercise price $0.0001 per share Exercise price for the pre-funded warrants.
Beneficial-ownership limitation 9.99% The warrants may not be exercised if exercise would put the reporting persons above this ownership level.
Pre-Funded Warrants financial
"immediately exercisable for shares of Common Stock"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OBIO shares do the reporting persons beneficially own?

They report shared beneficial ownership of 6,537,606 shares, or 8.15%, with shared voting and dispositive power.

Do Perceptive Advisors or Joseph Edelman directly hold OBIO shares or warrants?

Neither Perceptive Advisors nor Joseph Edelman directly holds common shares or pre-funded warrants; each reports shared voting and dispositive power over the reported position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68572M106

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading